Patents by Inventor Mark Laible

Mark Laible has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210371936
    Abstract: The present invention relates to methods of predicting the probability of an Oncotype DX® low risk recurrence score (RS) result (RS?25) for a breast cancer patient, to methods for selecting a breast cancer treatment, and to methods of treatment of breast cancer. It also relates to the use of a kit in these methods.
    Type: Application
    Filed: October 23, 2019
    Publication date: December 2, 2021
    Inventors: Mark Laible, Michael Oed, Ralph Wirtz
  • Publication number: 20210363594
    Abstract: The present invention relates to methods of predicting the probability of pathological complete response (pCR) of a breast cancer patient upon neo-adjuvant chemotherapy, to methods for selecting a breast cancer treatment, to methods of treatment of breast cancer, and to methods of prognosis of breast cancer upon breast cancer treatment.
    Type: Application
    Filed: September 26, 2019
    Publication date: November 25, 2021
    Inventors: Mark Laible, Michael Oed, Ralph Wirtz